Synthesis and pharmacological validation of a novel series of non-steroidal FXR agonists.

Bioorganic & Medicinal Chemistry Letters(2010)

引用 48|浏览12
暂无评分
摘要
To overcome the known liabilities of GW4064 a series of analogues were synthesized with increased potency in vitro and with superior lipid lowering effects in db/db mice compared to 6-ethyl-CDCA.
更多
查看译文
关键词
Farnesoid X receptor,FXR agonist,GW4064,db/db mice,Metabolic syndrome
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要